High-grade glioma (HGG), Diffuse intrinsic pontine glioma (DIPG) research hub

Adjuvant dendritic cell immunotherapy complementing conventional therapy for pediatric patients with high-grade glioma and diffuse intrinsic pontine glioma

This study is looking at a new type of treatment called a 'dendritic cell vaccine' for children with certain types of brain tumours (high-grade glioma and DIPG). It aims to see if the vaccine is safe and practical to use alongside their usual treatments.